1999
DOI: 10.1002/(sici)1096-9098(199902)70:2<116::aid-jso10>3.0.co;2-y
|View full text |Cite
|
Sign up to set email alerts
|

Laparoscopic splenectomy for non-Hodgkin lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0
1

Year Published

2001
2001
2004
2004

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 30 publications
(26 citation statements)
references
References 26 publications
1
24
0
1
Order By: Relevance
“…In nonHodgkin's lymphoma, splenic involvement occurs in 35% to 80% of cases and typically presents with symptoms of splenomegaly and hypersplenism [4,27,35]. Occasionally, non-Hodgkin's lymphoma presents with isolated splenic involvement [43]. In chronic lymphocytic leukemia, splenomegaly may be one of the earliest findings [43].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In nonHodgkin's lymphoma, splenic involvement occurs in 35% to 80% of cases and typically presents with symptoms of splenomegaly and hypersplenism [4,27,35]. Occasionally, non-Hodgkin's lymphoma presents with isolated splenic involvement [43]. In chronic lymphocytic leukemia, splenomegaly may be one of the earliest findings [43].…”
Section: Discussionmentioning
confidence: 99%
“…Occasionally, non-Hodgkin's lymphoma presents with isolated splenic involvement [43]. In chronic lymphocytic leukemia, splenomegaly may be one of the earliest findings [43]. In hairycell leukemia, splenomegaly may be the major finding, and subsequent splenectomy is associated with lasting remission [5].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In spite of the lack of studies with long-term follow-up, LS seems to provide similar results to OS in relation to hematological disease, mainly in ITP (Table 5) [60,61,62,63,64,65]. Recent studies highlight the interest in LS for treatment of hematological malignancies requiring splenectomy [66,67]. Furthermore, preliminary data suggest that cost for LS will ultimately equal or may even be less than open surgery (Table 6) Targarona (1990 [57] Park (1994)(1995)(1996)(1997)(1998) [ of similar age, weight, height, and type of complication.…”
Section: Ls and The Accessory Spleenmentioning
confidence: 98%
“…Inicialmente ela era considerada uma contra-indicação, mas a curva de aprendizado e a melhoria técnica alteraram esta situação 8,15 . Walsh et al 16 . descreveram que a EL é factível e segura mesmo na esplenomegalia associada a linfomas .…”
Section: Esplenectomia (N = 40)unclassified